Literature DB >> 22160603

Evaluation and management of small renal masses: looking beyond the tumor margin.

Michael Garcia-Roig1, Michael A Gorin, Merce Jorda.   

Abstract

In an effort to preserve renal function, nephron-sparing approaches such as partial nephrectomy are now routinely performed for the treatment of small renal masses (SRMs). To date, several groups have studied the utility of examining the renal parenchyma contained beyond the tumor margin of partial nephrectomy specimens for histopathologic evidence of non-neoplastic disease processes. The diagnosis of progressive renal disease through the study of this tissue allows for early medical intervention with possible further preservation of renal function. In this review, we discuss the management of SRMs with an emphasis on the emerging role of evaluating tumor specimens for non-neoplastic pathologic abnormalities. We believe that the thorough study of tissue contained beyond the tumor margin of partial nephrectomy specimens is the next step in preserving renal function and improving survival for patients with SRMs.

Entities:  

Mesh:

Year:  2012        PMID: 22160603     DOI: 10.1007/s11934-011-0228-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  42 in total

Review 1.  Clinical practice. Small renal mass.

Authors:  Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

Review 2.  Small renal masses: risk prediction and contemporary management.

Authors:  Yuka Yamaguchi; Matthew N Simmons; Steven C Campbell
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

Review 3.  Immunohistochemical diagnosis of renal neoplasms.

Authors:  Luan D Truong; Steven S Shen
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

4.  Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.

Authors:  Michael J Leveridge; Antonio Finelli; John R Kachura; Andrew Evans; Hannah Chung; Daniel A Shiff; Kimberly Fernandes; Michael A S Jewett
Journal:  Eur Urol       Date:  2011-06-24       Impact factor: 20.096

5.  The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.

Authors:  Toshinori Nishikimi; Toyonori Tsuzuki; Takashi Fujita; Naoto Sassa; Akitoshi Fukatsu; Satoru Katsuno; Yasushi Yoshino; Ryohei Hattori; Momokazu Gotoh
Journal:  Pathol Int       Date:  2011-01-09       Impact factor: 2.534

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

7.  Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus.

Authors:  Jared M Whitson; Adam C Reese; Maxwell V Meng
Journal:  Urol Oncol       Date:  2011-07-27       Impact factor: 3.498

8.  S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Authors:  G Li; A Barthelemy; G Feng; A Gentil-Perret; M Peoc'h; C Genin; J Tostain
Journal:  Histopathology       Date:  2007-04       Impact factor: 5.087

9.  The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.

Authors:  Matthew D Katz; Maria F Serrano; Peter A Humphrey; Robert L Grubb; Ted A Skolarus; Feng Gao; Adam S Kibel
Journal:  Urol Oncol       Date:  2009-11-13       Impact factor: 3.498

10.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.